Get the Stockscreener App
43.86
1.32%
0.57
Omnicell Inc stock is traded at $43.86, with a volume of 484.73K.
It is up +1.32% in the last 24 hours and up +18.99% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$43.29
Open:
$43.43
24h Volume:
484.73K
Relative Volume:
1.06
Market Cap:
$1.97B
Revenue:
$1.15B
Net Income/Loss:
$23.09M
P/E Ratio:
87.72
EPS:
0.5
Net Cash Flow:
$89.18M
1W Performance:
+8.31%
1M Performance:
+18.99%
6M Performance:
+46.49%
1Y Performance:
-4.57%
1-Day Range:
$42.72
$43.92
1-Week Range:
$39.18
$45.36
52-Week Range:
$22.66
$47.69
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
43.86 | 1.94B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
223.26 | 37.72B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.61 | 13.14B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
96.79 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
43.85 | 8.31B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
36.54 | 6.47B | 11.99B | 24.18M | 234.31M | 0.2956 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Omnicell Shares Surge on Robust Earnings and Strategic Product Launch - AD HOC NEWS
Analyst Calls: Will Omnicell Inc stock benefit from AI adoptionJuly 2025 Price Swings & Reliable Trade Execution Plans - moha.gov.vn
Omnicell (NASDAQ:OMCL) Downgraded to Hold Rating by Zacks Research - MarketBeat
Is Omnicell (OMCL) Expanding OmniSphere Into Nursing Units Enough To Reinforce Its Moat? - Yahoo Finance
Pharmacy Automation Systems Market to Reach US$ 12.05 Billion - openPR.com
Benchmark Maintains Omnicell (OMCL) Buy Recommendation - Nasdaq
Is Omnicell’s (OMCL) Titan XT Launch a Turning Point in Its SaaS Automation Strategy? - Sahm
Omnicell stock price target raised by BofA to $46 on new cabinet launch - Investing.com Canada
Health Systems Embrace New Strategies to Navigate Disruptions - 富途牛牛
Benchmark raises Omnicell stock price target to $50 on new Titan XT system - Investing.com Canada
Omnicell (OMCL) Stock Today: Titan XT Launch, New $50 Price Target and What It Means for 2025 Investors - ts2.tech
WINTON GROUP Ltd Makes New Investment in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Omnicell (NASDAQ:OMCL) Given New $50.00 Price Target at Benchmark - MarketBeat
Omnicell stock rises after launch of enterprise-level medication dispensing system - Investing.com Nigeria
Omnicell stock rises after launch of enterprise-level medication dispensing system By Investing.com - Investing.com South Africa
Omnicell Launches Advanced Titan XT Dispensing System - TipRanks
Omnicell launches Titan XT automated dispensing system for hospitals - Investing.com
Omnicell launches Titan XT automated dispensing system for hospitals By Investing.com - Investing.com South Africa
Omnicell, Inc. Launches Omnicell Titan XT Automated Dispensing System - TradingView
Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management - Yahoo Finance
Omnicell (OMCL) Valuation Check After Recent Share Price Rebound - Yahoo Finance
1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off - Markets Financial Content
Insider Sell: Corey Manley Sells Shares of Omnicell Inc (OMCL) - GuruFocus
Omnicell EVP & Chief Legal/Admin Officer Sells Shares - TradingView
Reasons to Add Omnicell Stock to Your Portfolio Right Now - Yahoo Finance
Why Omnicell Inc. (OC9) stock is favored by hedge fundsForecast Cut & Real-Time Volume Spike Alerts - Newser
Will Omnicell Inc. stock outperform tech sector in 2025Trade Volume Summary & Fast Moving Market Watchlists - Newser
Why Omnicell Inc stock could rally in 2025Market Performance Recap & Verified Short-Term Trading Plans - BỘ NỘI VỤ
Is Omnicell Inc. (OC9) stock undervalued at current price2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Is Omnicell Inc. (OC9) stock a good hedge against inflationTrade Analysis Report & Verified Swing Trading Watchlist - Newser
Why Omnicell Inc. (OC9) stock stays resilient2025 Price Momentum & Weekly High Return Stock Forecasts - Newser
Systematic Financial Management LP Acquires New Stake in Omnicell, Inc. $OMCL - MarketBeat
Will Omnicell Inc. (OC9) stock sustain uptrend momentum2025 Investor Takeaways & Verified Momentum Stock Alerts - Newser
Prudential Financial Inc. Cuts Stock Position in Omnicell, Inc. $OMCL - MarketBeat
VP Manley Files To Sell 6,106 Of Omnicell Inc [OMCL] - TradingView
Omnicell Chairman and CEO Randall A. Lipps Sells 28,250 Shares - TradingView
How Omnicell Inc. (OC9) stock gains from tech spendingDollar Strength & High Return Trade Opportunity Guides - Newser
Will Omnicell Inc. (OC9) stock keep raising dividendsWeekly Volume Report & Weekly Breakout Opportunity Watchlist - Newser
With Omnicell Stock Surging, Have You Considered The Downside? - Trefis
Aug Swings: Why Omnicell Inc stock could rally in 2025July 2025 Short Interest & Reliable Trade Execution Plans - moha.gov.vn
Will Omnicell Inc. (OC9) stock beat Nasdaq index returns2025 Investor Takeaways & Safe Investment Capital Preservation Plans - Newser
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show - BioSpace
Will Omnicell Inc. (OC9) stock deliver compounding returns2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Is Omnicell Inc. (OC9) stock trading at attractive multiplesBull Run & Technical Pattern Recognition Alerts - Newser
OMCL6251486 Bond Price and Chart — FINRA:OMCL6251486 - TradingView
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.60%
0.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):